Gilead

Gilead Awards $7.5 Million in Second Round of Grants to Advance HIV Cure Research

Press Release

FOSTER CITY, Calif., Oct. 25, 2017 /3BL Media/ -- Gilead Sciences, Inc.(NASDAQ:GILD) announced the second round of recipients of its HIV cure grants program. This new commitment will provide $7.5 million to support five additional HIV cure research initiatives led by top academic institutions and focused on translational research and efficacy studies in preclinical models.

Gilead Implements Emergency Disaster Response Procedures to Ensure Medicine Access

Press Release

FOSTER CITY, Calif., September 5, 2017 /3BL Media/ — Gilead has implemented emergency disaster response procedures as part of its Patient Support Programs, effective immediately. These procedures will enable continued access to Gilead’s medications for patients affected by Hurricane Harvey, who may otherwise be at risk for a lapse in therapy. 

Gilead Publishes Year in Review 2016

Press Release

FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.

The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include:

Gilead Ranked #4 on Fortune's 2016 "Change the World" List

Article

Fortune has ranked Gilead 4th among 50 companies that have made an "important social or environmental impact through their profit-making strategy and operations." Criteria included measurable impact, business results and degree of innovation.

Health Care Innovation Drives S&P Growth - The Minute

Multimedia with summary

Disruptive change in health care is having a booster effect on the economy. From the Affordable Health Care Act to biotech, innovations in services and products are generating record profits, according to the Wall Street Journal’s Kristen Scholer. While health care is only the third largest S&P 500 sector, it has been the largest contributor to overall earnings growth for the S&P in three of the last four quarters. The sector has lifted the overall fourth-quarter earnings growth rate more than any other, according to FactSet, a data firm.

Health Care Innovation Drives S&P Growth - The Minute

Multimedia with summary

Disruptive change in health care is having a booster effect on the economy. From the Affordable Health Care Act to biotech, innovations in services and products are generating record profits, according to the Wall Street Journal’s Kristen Scholer. While health care is only the third largest S&P 500 sector, it has been the largest contributor to overall earnings growth for the S&P in three of the last four quarters. The sector has lifted the overall fourth-quarter earnings growth rate more than any other, according to FactSet, a data firm.

Health Care Companies Report Rising Profits; University of Utah Health Care Hospital System is First in Country to Post Online Physician Reviews and Comments - Health Minute for December 19, 2012

Press Release

Health care companies are reporting rising profits, due to a growing demand for products and services from an aging population, and the addition of more consumers to health insurance coverage through the new Affordable Care Act. Revenue at Gilead, known for its HIV and hepatitis treatments, has increased 98 percent. Health care information services company Cerner has grown 37 percent, and has averaged 19 percent growth annually over the past 20 years.

Pages

Subscribe to Gilead